WuXi Biologics (WXXWY) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
0500M1B2B2B2B3B4B4BQ4 2023Q2 2024Q4 2024Q2 2025Q4 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q4 2023Q2 2024Q4 2024Q2 2025Q4 2025

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
050M100M150M200M250M300M350M400MQ4 2023Q2 2024Q4 2024Q2 2025Q4 2025

EBITDA

EBITDA
0100M200M300M400M500M600M700M800MQ4 2023Q2 2024Q4 2024Q2 2025Q4 2025

EPS

EPSEPS Diluted
000001111Q4 2023Q2 2024Q4 2024Q2 2025Q4 2025

Revenue Variation (%)

Revenue Variation
-226101418222630Q4 2023Q2 2024Q4 2024Q2 2025Q4 2025

Income Variation (%)

Gross Profit VariationOperating Income Variation
0255075100125150175200Q4 2023Q2 2024Q4 2024Q2 2025Q4 2025

Revenue YoY Variation (%)

Revenue YoY Variation
0815223038455260Q4 2023Q2 2024Q4 2024Q2 2025Q4 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
03875112150188225262300Q4 2023Q2 2024Q4 2024Q2 2025Q4 2025

Price-to-Earning Ratio

P/E Ratio
048111519222630Q4 2023Q2 2024Q4 2024Q2 2025Q4 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0250M500M750M1B1B2B2B2BQ4 2023Q2 2024Q4 2024Q2 2025Q4 2025

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
011223445Q4 2023Q2 2024Q4 2024Q2 2025Q4 2025

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q4 2023Q2 2024Q4 2024Q2 2025Q4 2025
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
0125M250M375M500M625M750M875M1BQ4 2023Q2 2024Q4 2024Q2 2025Q4 2025

Free Cash Flow

Cash At End Of Period
0250M500M750M1B1B2B2B2BQ4 2023Q2 2024Q4 2024

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
0100M200M300M400M500M600M700M800MQ4 2023Q2 2024Q4 2024Q2 2025Q4 2025
🏦 Balance Sheet
📈 Key Metrics